期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

霉酚酸的药代动力学及其影响因素 被引量：1

下载PDF
导出
作者 叶丽卡 谢志红
机构地区 广州医学院第二附属医院
出处 《今日药学》 CAS 2009年第3期34-36,41,共4页 Pharmacy Today
基金 广东省医院药学研究基金资助项目(编号:2008018) 广州市属高校科技资助项目(编号:61027)
关键词 霉酚酸酯 药代动力学 美国食品药品管理局 肾移植急性排斥反应 免疫抑制药物 自体免疫性疾病 免疫排斥反应 免疫抑制作用
分类号 R593.242 [医药卫生—内科学] R969.1 [医药卫生—药理学]
  • 相关文献

参考文献5

  • 1夏东亚,高凤荣,秦海旭,颜鸣.霉酚酸酯在中国健康人体内的药动学研究[J].沈阳部队医药,2006,19(3):173-175. 被引量：1
  • 2余自成,赵菊平,徐达,王祥慧,蔡卫民.霉酚酸在肾移植病人术后首次给药和稳态后的药代动力学[J].中国临床药理学杂志,2004,20(3):205-208. 被引量：12
  • 3Hideaki Kagaya,Kazuyuki Inoue,Masatomo Miura,Shigeru Satoh,Mitsuru Saito,Hitoshi Tada,Tomonori Habuchi,Toshio Suzuki. Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients[J] 2007,European Journal of Clinical Pharmacology(3):279～288
  • 4Zheng Jiao,Jian-yong Zhong,Ming Zhang,Xiao-jin Shi,Yun-qiu Yu,Wei-yue Lu. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies[J] 2007,European Journal of Clinical Pharmacology(1):27～37
  • 5Zheng Jiao,Yan Zhong,Jie Shen,Yun-qiu Yu. Simple High-Performance Liquid Chromatographic Assay, with Post-Column Derivatization, for Simultaneous Determination of Mycophenolic Acid and its Glucuronide Metabolite in Human Plasma and Urine[J] 2005,Chromatographia(7-8):363～371

二级参考文献12

  • 1卢晓阳,盛飞剑,申屠建中,黄明珠.固相萃取-高效液相色谱法测定肝移植病人血清中麦考酚酸浓度[J].中国药学杂志,2004,39(6):455-457. 被引量：8
  • 2[1]European Mycophenolate Mofetil Cooperative Study Group.Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection[J]. Lancet, 1995;345:1321-1325.
  • 3[2]The Triconinental Mycophenolate Mofetil Renal Transplantation Study Group. A blind, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation[ J].Transplantation , 1996;61:1029-1037.
  • 4[3]Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in cadaveric renal allograft recipients[J]. Transplantation, 1995;60:225-232.
  • 5[4]Nobuyuki S, Hikaru O,Toshio O, et al. Determination of a new immunosuppressant, mycophenolate mofetil,and its active metabolite, mycophenolic acid, in rat and human body fluids by high-performance liquid chromatography[J]. J Chromatogr B,1994;654:249-256.
  • 6[5]Maria S, Paul DN, Victor WA, et al. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure[J]. Clin Chem, 1998;44:1481-1488.
  • 7[6]Halloran P,Mathew T,Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized,double-blind,clinical studies in prevention of rejection[J]. Transplantation, 1997;63:39-47.
  • 8[7]Vanrenterghem Y, Squifflet JP, Forsythe J, et al. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renaltransplant recipients[J]. Transplant Proc, 1998;30:1290-1291.
  • 9[8]Bret F,Anthony M. Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation[J]. Drugs, 1996;51:278-298.
  • 10[9]Van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation[J].Transplantation, 1999;68:261-266.

共引文献11

同被引文献10

引证文献1

二级引证文献3

今日药学
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部